STAT
NOVEMBER 12, 2024
The last time Mark Palinski went to a Narcotics Anonymous meeting, he was asked to leave and never come back. He stills remembers the argument: All he had done was advocate for the use of the “gold standard” treatment opioid addiction, a common medication called buprenorphine. To Palinski, buprenorphine is a godsend.
Pharmacy Is Right For Me
NOVEMBER 4, 2024
Meet Lila, a passionate fourth-year Pharm.D. student at Auburn University Harrison College of Pharmacy. During her APPE rotation with the American Association of Colleges of Pharmacy , Lila opened up about her inspiring journey to find the perfect pharmacy school and how, with the guidance of mentors, she discovered her true “Pharmily.” How did you choose your pharmacy school/college or graduate program?
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Pharmacist
NOVEMBER 27, 2024
NHS England (NHSE) should commission community pharmacies to deliver a wider range of NHS vaccines including pneumonia, shingles, meningitis, RSV and routine childhood vaccinations, the Company Chemists' Association (CCA) has said. It noted that many pharmacies already offer these vaccines privately, and suggested that commissioning NHS vaccinations through community pharmacies could improve uptake in historically […] The post NHSE urged to commission pharmacy vaccinations appeared first o
PharmaVoice
NOVEMBER 11, 2024
Psychiatry is getting more targeted as drugmakers develop a new range of treatments for depression.
Speaker: Jennifer Hill
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
Express Pharma
NOVEMBER 28, 2024
Key Findings: 75 per cent pharma leaders emphasise the need for sustainable manufacturing practices Highlight digital integration as crucial for improving healthcare access 63 per cent CXOs cite the need for a single global product standard 50 per cent believe regulatory simplification and streamlining will drive growth EY Parthenon (EY-P) in partnership with the Organisation of Pharmaceutical Producers of India (OPPI), released a report titled ‘Viksit Bharat@2047: Transforming India from pharma
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
STAT
NOVEMBER 19, 2024
When Makena, a drug designed to prevent preterm births, hit the market in 2011 at $1,500 per dose, it drew rife backlash. The drug was based on an active ingredient that had been available for many years at a much lower cost. Confronted with the public outcry, the FDA took an unusual step: It allowed pharmacies to continue making their own copies of the drug through the practice of pharmacy compounding, selling it at a fraction of Makena’s price.
Drug Patent Watch
NOVEMBER 11, 2024
Effective management of drug patent portfolios is crucial for pharmaceutical companies to maintain market exclusivity, protect revenue streams, and drive innovation. A robust patent strategy aligned with business goals is essential for maximizing value and staying competitive in the pharmaceutical landscape.
The Pharmacist
NOVEMBER 13, 2024
Pharmacy owners in England, Wales and Northern Ireland have voted in favour of taking collective action, according to a ballot carried out by the National Pharmacy Association (NPA). Some 99% of participating pharmacy owners said they were willing to limit their services unless funding is improved. The NPA said that subject to agreement from its […] The post Pharmacy owners vote overwhelmingly in favour of collective action appeared first on The Pharmacist.
PharmaVoice
NOVEMBER 5, 2024
Sernova’s technology helped type 1 diabetes patients achieve insulin independence in early- and mid-stage trials.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Express Pharma
NOVEMBER 30, 2024
“The first wealth is health,” said the American philosopher Ralph Waldo Emerson in 1860, and strides in life sciences entrepreneurship pronouncedly affect this form of wealth in any country. In India, the life sciences innovation, which includes pharma, biotech, and medtech, is valued at $30 billion in 2024. The country’s health metrics, such as the growing burden of non-communicable diseases, rising life expectancy, malnutrition, and air pollution, present a further scope for innovations
European Pharmaceutical Review
NOVEMBER 26, 2024
Glucagon-like peptide-1 (GLP-1) receptor agonists have shown to provide meaningful benefits in chronic kidney disease (CKD) and individuals with and without diabetes. This based on the largest, most comprehensive analysis of GLP-1 antagonists on kidney and cardiovascular outcomes. While GLP-1 receptor agonists have shown benefit for type 2 diabetes, obesity and cardiovascular disease, its impact as a treatment in chronic kidney disease is not as clear, the researchers explained.
STAT
NOVEMBER 22, 2024
The Food and Drug Administration approved on Friday a new medicine from BridgeBio for patients with a progressive heart disease — the first new treatment for the condition in over five years and the company’s first significant commercial product. The drug, known scientifically as acoramidis, will be sold by BridgeBio under the brand name Attruby.
Drug Patent Watch
NOVEMBER 18, 2024
The concept of a blockbuster drug, defined as a medication generating at least $1 billion in annual sales, has long been a cornerstone of the pharmaceutical industry. However, the question arises whether a drug can achieve blockbuster status without heavily relying on U.S. sales.
Advertisement
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
The Pharmacist
NOVEMBER 27, 2024
The government has been urged to intervene over the ‘devastating’ and ‘growing’ impact of medicines shortages across the UK. Some 20 pharmacy and patient groups have written to health and social care secretary Wes Streeting calling for a ‘cohesive cross-government’ strategy that would help strengthen the medicines supply chain and better protect access to medicines. […] The post Call for government strategy to tackle 'devastating impact' of medicines shortages appeared first on T
PharmaVoice
NOVEMBER 21, 2024
A subcutaneous version of Merck’s Keytruda was as effective as the infused version in a late-stage study, but the company won’t be the first to market.
Express Pharma
NOVEMBER 27, 2024
Contract manufacturing revenues in the pharmaceutical finished dose sector witnessed a significant slowdown over the past financial year. Challenging market conditions, driven by drug pricing pressures, regulatory shifts, and geopolitical tensions, have reshaped the landscape, offering both hurdles and opportunities for contract manufacturing organisations (CMOs) to adapt and innovate amidst global generic shortages, reveals GlobalData.
Pharmafile
NOVEMBER 13, 2024
Earlier in November, Johnson & Johnson innovative medicine have applied to the US Food and Drug Agency (FDA) and the European Medicines agency (EMA) for the approval of a new indication for DARAZALEX FASPRO (daratumumab and hyluronidase-fihj). DARAZLEX FASPRO would be used as a monotherapy for the treatment of high-risk smoldering multiple myeloma in adult […] The post J&J seek approval for first drug to treat high-risk smoldering myeloma appeared first on Pharmafile.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
NOVEMBER 19, 2024
Although more pharmaceutical companies are tailoring their business models to focus on low-income countries, a new analysis finds that overall industry efforts remain limited and patient access continues to suffer as a result. Notably, momentum has stalled in reaching licensing deals that are designed to make lower-cost generic drugs available in parts of the world where brand-name medicines are unaffordable, and few companies have pursued technology transfer agreements.
Drug Patent Watch
NOVEMBER 24, 2024
Patient centricity has become a crucial aspect of the pharmaceutical industry, particularly in the development of generic drugs. This approach focuses on understanding and addressing the needs and preferences of patients to ensure that the medications they receive are safe, effective, and easy to use.
The Pharmacist
NOVEMBER 22, 2024
A pharmacy-led sore throat treatment service in Wales has been found to result in fewer same-day antibiotic prescriptions than those given during GP consultations, according to a new study. The study, published in the Journal of Antimicrobial Chemotherapy, found that pharmacy-led sore throat treatment provides a safe, effective, and cost-efficient alternative to GP consultations.
PharmaVoice
NOVEMBER 26, 2024
Stoke Therapeutics is entering phase 3 with its RNA medicine designed to treat a rare epileptic condition.
Speaker: Joe Sharpe and James Carlson
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
Express Pharma
NOVEMBER 21, 2024
Union Minister Dr Jitendra Singh formally launched the first indigenous antibiotic “Nafithromycin” for resistant infections. It is only after 2014, when Prime Minister Narendra Modi took over that our researchers received the right kind of support to explore their potential, said Dr Jitendra Singh. The antibiotic Nafithromycin has been developed with the support of the Biotechnology Industry Research Assistance Council (BIRAC), a unit of the Department of Biotechnology and has been brought to ma
The Guardian - Pharmaceutical Industry
NOVEMBER 9, 2024
As UK diagnoses have doubled, prescriptions of the treatment have halved. While experts feud over its use, many patients feel it is an effective way of managing their condition Occupational stress is a trigger for Rebecca Wilde, a 32-year-old tech worker in Buckinghamshire. Four years ago, work pressures combined with family issues affected her sleep, leading to a severe manic episode.
STAT
NOVEMBER 4, 2024
This is Part 5 of “Behind the Counter,” an in-depth video series demystifying the complex world of patents and drug pricing. When patents for name brand medicines expire, the price of that medicine drops significantly as generic versions enter the market. Lower prices are good news for patients seeking more affordable medications, but the change can sometimes take a while.
Drug Patent Watch
NOVEMBER 18, 2024
The pharmaceutical industry is undergoing a significant shift, with emerging markets offering the next growth opportunity. This growth is driven by several factors, including the increasing prevalence of chronic diseases, cost-effectiveness, and patent expirations of branded drugs.
Advertisement
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
The Pharmacist
NOVEMBER 18, 2024
NICE is consulting on a proposal to add cytisine as a treatment option to its stop smoking guidelines. This proposal follows a review of recent evidence which suggests patients who received cytisine were 30% more likely to not smoke for six months or longer, when compared to placebo or no medication. The drug was made […] The post Cytisine pill could be added to stop smoking guidelines appeared first on The Pharmacist.
PharmaVoice
NOVEMBER 8, 2024
Past comments hint at the changes Robert F. Kennedy Jr. could make across the various sectors of healthcare.
Express Pharma
NOVEMBER 28, 2024
Dr. Reddy’s Laboratories announced the launch of Toripalimab, immuno-oncology drug in India. Toripalimab is a New Biological Entity (NBE). It is approved by various regulatory authorities around the world such as the United States Food and Drug Administration (USFDA), European Medicines Agency (EMA), Medicines and Healthcare Products Regulatory Agency (MHRA), and others for the treatment of adults with recurrent or metastatic nasopharyngeal carcinoma (RM-NPC).
Expert insights. Personalized for you.
363 
Let's personalize your content